Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
The Big Pharma Psychedelic Buyout Spree Has Begun
Massive validation for psychedelics…not as drugs, but as investments could be moments away. Just months after I argued for the millionth time that psychedelic drug developers were likely to become acquisition targets as the sector gained…
Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US
FDA endorses key elements of the proposed Phase 2 dose-ranging study and openness to a single pivotal Phase 3 study to support a future NDA Amsterdam, the Netherlands, 16 July 2026 — Arletta Pharma Solutions, a clinical-stage…
Wonder's $650m raise, Crypto.com's $20b valuation, Angelini Pharma seals rare disease buy
• Wonder, an NYC-based cloud kitchen company, raised $650m in Series D funding at a $9b valuation. Investors include Accel, GV, New Enterprise Associates, AllianceBernstein, ARK Invest and Kayne Anderson Rudnick Investment Management. Go…
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
Determining where to allocate capital in the healthcare sector often involves choosing between established stability and aggressive growth. Both Johnson & Johnson (JNJ +2.10%) and Eli Lilly and Co (LLY +1.31%) offer unique paths for investors.
Explained: How the India-UK CETA could boost pharma, medtech exports
The India-UK Comprehensive Economic and Trade Agreement (CETA) is expected to create a significant export opportunities for India's pharmaceutical, medical devices and healthcare sectors by providing duty-free access to the UK market and easing…
Citigroup Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target lifted by research analysts at Citigroup from $82.00 to $93.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a 'neutral' rating on the stock.
HC Wainwright Lowers Earnings Estimates for NervGen Pharma
NervGen Pharma (NASDAQ:NGEN - Free Report) - Investment analysts at HC Wainwright cut their Q2 2026 earnings per share estimates for NervGen Pharma in a research note issued on Tuesday, July 14th. HC Wainwright analyst R. Selvaraju now anticipates…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - What's Next?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s stock price gapped up prior to trading on Thursday. The stock had previously closed at $19.24, but opened at $20.14. Ascentage Pharma Group International…
Athira Pharma, Inc. (NASDAQ:LONA) Receives Average Rating of 'Hold' from Analysts
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) has earned an average rating of 'Hold' from the five research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has…
FDA approves first pill to significantly lower 'bad' cholesterol
July 16 (UPI) -- Heralding what some are calling a revolution in cholesterol management, U.S. regulators on Thursday approved the use of pill shown to significantly reduce dangerous 'LDL-C' cholesterol in at-risk adults. The Food and Drug…
India-U.K. CETA to spur sourcing of textiles, food produce from Telangana, help attract more GCCs
The India–UK Comprehensive Economic and Trade Agreement (CETA) that came into force on July 15 is expected to spur demand for textiles, agri produce, spices and marine products from the Telugu States, besides making several British firms…
Why Customer Care Is More Of A Growth Engine Than A Cost Center
Jennifer Waters, SVP at BioCareSD, is a leading voice in specialty pharma, championing transparency and industry innovation. The pop-up chatbot. The automated phone tree. The “your call is very important to us” recording…
Chinese drugmakers with big ambitions struggle to recruit staff for global expansion
Leading Chinese drugmakers with global ambitions such as Jiangsu Hengrui Pharmaceuticals and CanSino Biologics are struggling to recruit internationally experienced staff needed to develop and commercialise promising medicines overseas, industry…
CMOs Should Question How AI Agents Make Decisions
AI agents can change budgets, shift target audiences, personalize messages, and move to the next decision before anyone on the marketing team sees what happened. By the time, a human review a dashboard, thousands of decisions may already be in…
I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade) (NYSE:JNJ)
Johnson & Johnson posted strong Q2 earnings. Sales of its NMDA receptor antagonist, called Spravato, for the treatment of depression, rose 41.1% year-on-year to $584 million in Q2. Also, J&J raised its 2026 adjusted diluted EPS guidance from…
Receive a Daily briefing on Pharma Industry News
Get Started